与原发性中芽细胞瘤相关的第二次血液恶性病:基于人口的研究
David Aguiar-Bujanda1, Laura Croissier-Sánchez, Daniel Pérez-Cabrera
1Department of Medical Oncology, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.
American journal of clinical oncology
|October 19, 2023
概括
患有原发性中枢胚芽细胞瘤 (PMGCT) 的患者面临显著增加患第二次血液性恶性瘤 (SHM) 的风险,特别是急性髓性白血病. 这凸显了对这些潜在的长期并发症的警监测和意识的需要.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- 在初级介质胚芽细胞瘤 (PMGCT) 患者的第二次血液性恶性瘤 (SHMs) 尚未研究.
- 这项研究通过分析大量基于人口的案例系列来解决数据稀缺的问题.
研究的目的:
- 描述PMGCT患者中SHM的临床特征和发病率.
- 与一般人群相比,量化该人群中SHM的风险.
主要方法:
- 使用了监测,流行病学和最终结果 (SEER) 数据库.
- 分析了1297例PMGCT以确定SHMs的发生情况.
主要成果:
- 在PMGCT患者中发现了27例 (2.08%) 的SHM,中位延迟时间为12个月.
- 急性髓性白血病是最常见的SHM (13例),其中包括4例急性巨核细胞白血病.
- 关节性肌肉疾病的风险明显高于预期 (标准化发病率=6.21).
结论:
- 患有PMGCT的患者患上SHMs的风险显著增加,尤其是急性髓性白血病.
- 这些发现表明,SHM和PMGCT疗法之间存在潜在的联系.
- 建议包括加强后续时间表和增加PMGCT幸存者对SHM的临床怀疑.
更多相关视频
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Bone Marrow Sampling and Transplants
341
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
341
Primary Lymphoid Organs
1.6K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
1.6K
Production of Formed Elements
1.4K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.4K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K


